NO20083637L - anvendelse av alkandikarboksylsyrer og retinoider for behandling av rosacea og andre inflammatoriske hudsykdommer - Google Patents

anvendelse av alkandikarboksylsyrer og retinoider for behandling av rosacea og andre inflammatoriske hudsykdommer

Info

Publication number
NO20083637L
NO20083637L NO20083637A NO20083637A NO20083637L NO 20083637 L NO20083637 L NO 20083637L NO 20083637 A NO20083637 A NO 20083637A NO 20083637 A NO20083637 A NO 20083637A NO 20083637 L NO20083637 L NO 20083637L
Authority
NO
Norway
Prior art keywords
rosacea
treatment
skin diseases
inflammatory skin
retinoids
Prior art date
Application number
NO20083637A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas Zollner
Sonke Johannsen
Original Assignee
Intendis Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intendis Gmbh filed Critical Intendis Gmbh
Publication of NO20083637L publication Critical patent/NO20083637L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20083637A 2006-01-23 2008-08-22 anvendelse av alkandikarboksylsyrer og retinoider for behandling av rosacea og andre inflammatoriske hudsykdommer NO20083637L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76095206P 2006-01-23 2006-01-23
DE102006004804A DE102006004804A1 (de) 2006-01-23 2006-01-23 Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen
PCT/EP2007/000804 WO2007082780A1 (fr) 2006-01-23 2007-01-23 Utilisation d’acides alcanedicarboxyliques et de retinoides pour le traitement de l’acne rosacee et d’autres maladies inflammatoires de la peau

Publications (1)

Publication Number Publication Date
NO20083637L true NO20083637L (no) 2008-10-07

Family

ID=38219816

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083637A NO20083637L (no) 2006-01-23 2008-08-22 anvendelse av alkandikarboksylsyrer og retinoider for behandling av rosacea og andre inflammatoriske hudsykdommer

Country Status (14)

Country Link
US (1) US20110160306A1 (fr)
EP (2) EP2316444A3 (fr)
JP (1) JP2009523750A (fr)
KR (1) KR20080086515A (fr)
CN (1) CN101370489A (fr)
AU (1) AU2007207027A1 (fr)
BR (1) BRPI0707180A2 (fr)
CA (1) CA2633774A1 (fr)
DE (1) DE102006004804A1 (fr)
IL (1) IL191908A0 (fr)
NO (1) NO20083637L (fr)
RU (1) RU2008134316A (fr)
SG (1) SG169332A1 (fr)
WO (1) WO2007082780A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2201930A1 (fr) 2008-12-23 2010-06-30 Intendis GmbH Composition d'hydrogel pour le traitement des troubles dermatologiques
US20100273756A1 (en) * 2009-04-27 2010-10-28 Reza Babapour Adjunctive formulation and methods for palliation of fine wrinkles, mottled hyperpigmentation, tactile roughness of facial skin and related disorders
DE102010021671A1 (de) 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz
TW201311295A (zh) * 2011-06-03 2013-03-16 Allergan Inc 對皮脂腺之類視色素化合物之目標遞送
RU2500395C1 (ru) * 2012-12-07 2013-12-10 Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" Мазевая композиция для местного применения с противоугревой фармакологической активностью
WO2017019951A2 (fr) 2015-07-30 2017-02-02 Curology, Inc. Compositions et procédés de traitement de l'acné et du photovieillissement
WO2017192928A1 (fr) 2016-05-06 2017-11-09 Albany Medical College Traitement de la rosacée avec des inhibiteurs de la voie p38 et erk kinase
US12150949B2 (en) 2018-07-30 2024-11-26 Curology, Inc. Compositions and methods of treating acne and photoaging
KR102081029B1 (ko) * 2019-08-12 2020-02-25 연세대학교 산학협력단 수베르산 또는 이의 염을 유효성분으로 포함하는 알러지성 질환 또는 아토피 피부염 예방 또는 치료용 조성물
WO2021029659A1 (fr) * 2019-08-12 2021-02-18 연세대학교 산학협력단 Composition destinée à prévenir ou traiter des maladies allergiques ou une dermatite atopique comprenant de l'éthylvanilline, de l'acide subérique, du thiazole ou un sel de ceux-ci en tant que principe actif
CN114518416B (zh) * 2020-11-20 2024-05-24 上海交通大学医学院附属瑞金医院 一种判断银屑病对il-17a抗体应答反应及其复发的标志物
CN116710087A (zh) * 2020-11-23 2023-09-05 美国商业眼科医疗器械公司 用于治疗眼部病症的制剂和方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1075741B (it) 1977-04-19 1985-04-22 Porro Marcella Composizione per il trattamento di dermatosi iperpigmentarie
US4661519A (en) * 1983-04-12 1987-04-28 Pola Chemical Industries Inc. Method for dermatological application
US5326790A (en) * 1986-11-19 1994-07-05 Dermatologic Research Corporation Administration of skin medications by use of dicarboxylic acids and derivatives
DE3811081A1 (de) 1988-03-30 1989-10-12 Schering Ag Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut
IT1242478B (it) 1990-02-20 1994-03-17 Schering Spa Composizioni farmaceutiche ad attivita' depigmentante e contro il danneggiamento cutaneo fotoindotto.
FR2714602B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition antiacnéique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
JP2001509137A (ja) * 1996-11-12 2001-07-10 タマーキン ファーマシューティカル イノベイション リミテッド 皮膚疾患の治療方法
CN1091371C (zh) 1996-12-26 2002-09-25 苏洪国 换肤粉刺霜
SE9801647D0 (sv) * 1998-05-12 1998-05-12 Interhealth Ab Therapeutic composition
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
US6358541B1 (en) * 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
GB0128052D0 (en) * 2001-11-22 2002-01-16 Drug Discovery Lab As Compounds
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US7328924B2 (en) * 2003-12-12 2008-02-12 Phd, Inc. Adjustable tip assembly
US20050169948A1 (en) * 2004-01-29 2005-08-04 Bernstein Joel E. Method and compositions for treatment of acne vulgaris and acne rosacea
ITBS20040068A1 (it) * 2004-05-24 2004-08-24 Gen Topics Srl Composizione cosmetica e/o farmaceutica per il trattamento della rosacea

Also Published As

Publication number Publication date
JP2009523750A (ja) 2009-06-25
BRPI0707180A2 (pt) 2011-04-26
CA2633774A1 (fr) 2007-07-26
AU2007207027A1 (en) 2007-07-26
RU2008134316A (ru) 2010-02-27
CN101370489A (zh) 2009-02-18
KR20080086515A (ko) 2008-09-25
EP2316444A3 (fr) 2011-06-01
WO2007082780A1 (fr) 2007-07-26
DE102006004804A1 (de) 2007-07-26
US20110160306A1 (en) 2011-06-30
SG169332A1 (en) 2011-03-30
IL191908A0 (en) 2009-08-03
EP2316444A2 (fr) 2011-05-04
EP1976499A1 (fr) 2008-10-08

Similar Documents

Publication Publication Date Title
NO20083637L (no) anvendelse av alkandikarboksylsyrer og retinoider for behandling av rosacea og andre inflammatoriske hudsykdommer
Yang et al. Advances in the human skin microbiota and its roles in cutaneous diseases
Karagounis et al. Use of “natural” oils for moisturization: Review of olive, coconut, and sunflower seed oil
Tanghetti et al. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization
NZ618734A (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
SG10201400685SA (en) Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia
EA201290108A1 (ru) Составы в виде везикул
BRPI0916456B8 (pt) compostos lipídicos, composições de suplemento alimentar, farmacêuticas e lipídicas, método para produção de compostos lipídicos e uso de compostos lipídicos
BR112014032905A2 (pt) métodos de redução do risco de um evento cardiovascular em um sujeito em terapia com estatina
BR112012018256A8 (pt) método de tratamento de doença de parkinson
BR112018000734A2 (pt) composições tópicas retinoicas
BRPI0919020A2 (pt) Uso de células de linhagem monocitária enriquecidas para tratar isquemia e para tratar angina pectoris
JP2014527024A5 (fr)
BR112014005546A2 (pt) ácidos graxos ômega para tratamento de doenças
JP2015508094A (ja) Ｄｇｌａ、１５−ｏｈｅｐａ、及び／又は１５−ｈｅｔｒｅを含む医薬組成物並びにこれを使用する皮脂生成の低減法
UA112418C2 (uk) Терапевтичний болезаспокійливий засіб
BRPI0510370A (pt) derivados de ácido fenoxi-alquil-carboxìlico no tratamento de doenças inflamatórias
EA200700044A1 (ru) Композиция для местного применения
US11224618B2 (en) Formulations and methods for treatment of acne and inflammatory skin conditions
EP4461359A3 (fr) Composition pour utilisation externe sur la peau pour des maladies inflammatoires
BR112013005703A2 (pt) máscara facial de polivinila para descamação para tratamento de afecções de pele que compreende uma alta concentração de ácido retinóico
KR20210148183A (ko) 염증성 피부병을 위한 덱스트란 설페이트
RU2014102494A (ru) Ретиноидные композиции местного применения и способы лечения состояний кожи
RU2014101705A (ru) Пленкообразующая композиция и ее применение для лечения герпеса
RU2007135881A (ru) Композиция для снижения экссудации белков сыворотки

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application